"Designing Growth Strategies is in our DNA"

Anti-obesity Drugs Market Size, Share & Industry Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI104783

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Obesity - By Key Countries/Region
    2. New Product Launches
    3. Key Industry Developments – Mergers, Acquisition, and Partnerships
    4. Pipeline Analysis
    5. Impact of COVID-19 on the Global Market
  5. Global Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. India
      2. China
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Novo Nordisk A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GlaxoSmithKline
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Vivus Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Currax Pharmaceuticals LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Sandoz International GmbH (Novartis AG)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Anti-obesity Drugs Market Value Share (%), By Type, 2023 & 2032

Figure 02: Global Anti-obesity Drugs Market Value Share (%), By Distribution Channel, 2023 & 2032

Figure 03: Global Anti-obesity Drugs Market Value Share (%), By Region, 2023 & 2032

Figure 04: North America Anti-obesity Drugs Market Value (USD billion), by Type, 2023 & 2032

Figure 05: North America Anti-obesity Drugs Market Value Share (%), by Type, 2023

Figure 06: North America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 07: North America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 08: North America Anti-obesity Drugs Market Value (USD billion), by Country, 2023 & 2032

Figure 09: North America Anti-obesity Drugs Market Value Share (%), by Country, 2023

Figure 10: Europe Anti-obesity Drugs Market Value (USD billion), by Type, 2023 & 2032

Figure 11: Europe Anti-obesity Drugs Market Value Share (%), by Type, 2023

Figure 12: Europe Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 13: Europe Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 14: Europe Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 15: Europe Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2023

Figure 16: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Type, 2023 & 2032

Figure 17: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Type, 2023

Figure 18: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 19: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 20: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 21: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2023

Figure 22: Latin America Anti-obesity Drugs Market Value (USD billion), by Type, 2023 & 2032

Figure 23: Latin America Anti-obesity Drugs Market Value Share (%), by Type, 2023

Figure 24: Latin America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 25: Latin America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 26: Latin America Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 27: Latin America Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2023

Figure 28: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Type, 2023 & 2032

Figure 29: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Type, 2023

Figure 30: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 31: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 32: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 33: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2023

Figure 34: Global Anti-obesity Drugs Market Share (%), By Company, 2023

Table 01: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 03: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Region, 2019–2032

Table 04: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 05: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 06: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 07: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 08: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 09: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 10: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 11: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 12: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 13: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 14: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 15: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 16: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 17: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 18: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Anti-obesity Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 130
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase